CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function Post Anterior Myocardial Infarction - Pilot Study
Phase of Trial: Phase I
Latest Information Update: 08 Jan 2019
Price : $35 *
At a glance
- Drugs Cenderitide (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions; Proof of concept
- Acronyms BELIEVE III
- 03 Jan 2019 Status changed from recruiting to completed.
- 29 Aug 2016 Planned End Date changed from 1 Jun 2017 to 1 Dec 2016.
- 29 Aug 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Oct 2016.